Farringdon Capital, Ltd. Quest Diagnostics Inc Transaction History
Farringdon Capital, Ltd.
- $198 Billion
- Q1 2025
A detailed history of Farringdon Capital, Ltd. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 2,343 shares of DGX stock, worth $321,201. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,343
Previous 3,763
37.74%
Holding current value
$321,201
Previous $568 Million
30.17%
% of portfolio
0.2%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding DGX
# of Institutions
1,066Shares Held
102MCall Options Held
468KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA13.9MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.98MShares$820 Million0.12% of portfolio
-
State Street Corp Boston, MA5.18MShares$710 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY3.77MShares$517 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...